Literature DB >> 9175399

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis.

R A DeFronzo1.   

Abstract

Insulin resistance syndrome (IRS) has the potential to explain a large group of common metabolic and cardiovascular disorders [e.g., obesity, non-insulin-dependent diabetes mellitus (NIDDM), hypertension, hyperlipidaemia, hypercoagulability] which are all in themselves cardiovascular risk factors. This contribution firstly reviews the convincing evidence from glucose-clamp studies that all of these conditions are characterised by the presence of combined insulin resistance and hyperinsulinaemia, and secondly examines the relationships of the components of this syndrome to coronary artery disease and to the rational choice of antihypertensive therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9175399     DOI: 10.1016/s0300-2977(97)00012-0

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  78 in total

1.  Identification of glucose transporter 4 knockdown-dependent transcriptional activation element on the retinol binding protein 4 gene promoter and requirement of the 20 S proteasome subunit for transcriptional activity.

Authors:  Erina Inoue; Aoi Yamashita; Hirofumi Inoue; Mariko Sekiguchi; Asuka Shiratori; Yuji Yamamoto; Tadahiro Tadokoro; Yoshiko Ishimi; Jun Yamauchi
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

2.  A rare cardiac finding in a morbidly obese patient with severe hypertension.

Authors:  Anna Maria Vittoria Fiore; Giorgia Michela Marinoni; Alessandro Piccione; Maria Adelaide Marini; Monica D'Adamo; Renato Lauro; Paolo Sbraccia
Journal:  Intern Emerg Med       Date:  2010-10-09       Impact factor: 3.397

Review 3.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

4.  Sleeping oxygen saturation, rapid eye movement sleep, and the adaptation of postprandial metabolic function in insulin sensitive and resistant individuals without diabetes.

Authors:  Karin A Garcia; William K Wohlgemuth; Ele Ferrannini; Andrea Mari; Alex Gonzalez; Armando J Mendez; Roberto Bizzotto; Jay S Skyler; Neil Schneiderman; Barry E Hurwitz
Journal:  Physiol Behav       Date:  2018-04-12

5.  Exposure to p,p'-dichlorodiphenyldichloroethylene (DDE) induces fasting hyperglycemia without insulin resistance in male C57BL/6H mice.

Authors:  George E Howell; Edward Meek; Jessica Kilic; Mariel Mohns; Charlee Mulligan; Janice E Chambers
Journal:  Toxicology       Date:  2014-02-26       Impact factor: 4.221

Review 6.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

7.  FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Ann Piccirillo; Yong Fan; Radha Uppala; Eric Goetzman; H Henry Dong
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

8.  N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.

Authors:  Duangporn Thong-Ngam; Suchittra Samuhasaneeto; Onanong Kulaputana; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

9.  Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats.

Authors:  Ke-Xin Gan; Chao Wang; Jin-Hu Chen; Chun-Jing Zhu; Guang-Yao Song
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

10.  Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants.

Authors:  M A Abdul-Ghani; R Jani; A Chavez; M Molina-Carrion; D Tripathy; R A Defronzo
Journal:  Diabetologia       Date:  2009-01-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.